Summary

  • Onto paid approximately $720 million for 27% of Rigaku and one board nomination, but Rigaku remains independent and its revenue will not be consolidated into Onto’s accounts.
  • Investors must keep two scorecards: the mark-to-market value of the stake and the operating evidence that joint X-ray, optical and analytical capabilities are becoming qualified products, orders and attributable economics.

The cleanest way to read Onto Innovation’s investment in Rigaku is to begin at the accounting boundary. Roughly $720 million has crossed that boundary and entered Onto’s balance sheet. Rigaku’s sales have not. Onto bought 61,123,436 shares, equal to 27% of the Japanese X-ray measurement specialist, and secured the right to nominate one director. It did not buy a subsidiary.

That distinction matters because the transaction is easy to describe with the language of industrial combination even though its legal and financial architecture is one of influence without consolidation. Rigaku keeps its management independence. The agreement contains restrictions on transfers and additional acquisitions. Onto elected the fair-value option for the holding and said it would not consolidate Rigaku. Future changes in the investment’s reported value can therefore move through Onto’s financial statements without any corresponding addition of Rigaku revenue to Onto’s top line.

The price itself contains a useful lesson. The parties fixed the acquisition at ¥1,850 a share, or ¥113.078 billion in total. Onto’s April announcement described that as about $710 million; the closing announcement in August used about $720 million. The yen consideration did not change. The dollar shorthand did. A reader who treats the two dollar figures as different deal prices would manufacture a development that never occurred.

At the agreed price, a simple division of the stake value by 27% implies an equity value of roughly ¥418.8 billion for all of Rigaku. That is a transaction extrapolation, not a public-market target and not an assertion that every share can be bought or sold at the same terms. The holding also brings liquidity, governance and transfer constraints that make it different from cash or a freely traded strategic portfolio.

Two assets, not one

Onto has effectively acquired two assets with different paths to value. The first is a financial claim on 27% of Rigaku. Its reported value can respond to Rigaku’s performance, market assumptions, currency and the mechanics of the fair-value election. The second is an operating option: preferential access to combine Rigaku’s X-ray metrology with Onto’s optical metrology, model-based analytics and software.

The first asset can appreciate without proving the second. Rigaku could improve as a business while the alliance produces few products for Onto’s customers. The reverse is also possible: the collaboration could create strategically important tools while near-term fair-value movements make the stake look disappointing. Collapsing both outcomes into a single story about “synergy” would obscure the transaction’s actual risk.

The industrial proposition is nonetheless coherent. As semiconductor structures become smaller, deeper and more three-dimensional, no single measurement method sees every relevant feature with the same speed, sensitivity and cost. X-ray techniques can reveal buried structures and material properties. Optical systems can provide high-throughput measurements and broad production coverage. Model-based analysis and machine learning can reconcile signals that are individually incomplete.

A hybrid system can be worth more than a collection of adjacent instruments if it shortens recipes, improves confidence or catches process drift that one modality would miss.

Rigaku and Onto already point to an integration of critical-dimension small-angle X-ray scattering with Onto’s model-based analytics. Their broader plan covers X-ray, optical and AI-enabled hybrid metrology. That is a credible technical direction. It is not yet evidence of a repeatable commercial engine.

Qualification is the bridge between technical plausibility and revenue. A semiconductor manufacturer must test whether a tool works on the intended structures, fits cycle-time and contamination rules, integrates with factory data and produces stable results across wafers, lots and sites. Named products, customer qualifications, production orders and service or software attach would show that the bridge is being crossed. General references to collaboration do not.

The $300 million number belongs to Rigaku

Rigaku has identified at least $300 million of incremental market opportunity for its products by 2030. That figure is useful as an expression of ambition and addressable demand. It is not backlog, booked revenue or a forecast of Onto’s revenue. It is also not an entitlement for Onto to 27% of $300 million. Equity ownership, product sales, alliance economics and consolidated accounting are separate channels.

The distinction prevents several tempting shortcuts. A sale of a Rigaku X-ray instrument may benefit the value of Onto’s stake, but it does not automatically appear as Onto product revenue. A joint application may include Onto software or optical content, but the revenue split depends on product architecture and commercial agreements that have not been disclosed in detail. A future Rigaku dividend could send cash to Onto, while retained earnings could instead support Rigaku’s own growth. Each path has a different margin, timing and valuation effect.

For the alliance to earn an operating premium, disclosures eventually need to move from capability nouns to commercial verbs. Which combined products entered evaluation? Which were qualified? Which generated repeat orders? How much Onto content was attached? Did the combination improve gross margin, service revenue, working capital or customer concentration? Without those answers, the investment remains strategically suggestive but economically under-specified.

A balance sheet with financing layers

The acquisition also sits beside Onto’s 2026 financing. The company issued $1.5 billion principal amount of 0% convertible senior notes due 2031 and reported approximately $1.47 billion of net proceeds before offering expenses. It spent about $88.9 million on capped-call transactions and about $204.9 million repurchasing shares; the remainder was available for general corporate purposes, which could include the Rigaku investment.

The notes carry an initial conversion price of $381.80, representing about 3.9 million shares at the initial rate and as many as roughly 5.9 million under specified adjustments. Onto expects to settle principal in cash; any value above principal may be settled in cash, shares or a combination. The capped calls are intended to reduce potential dilution or offset cash payments above principal within their limits, not to erase every financing risk.

This structure means the Rigaku thesis cannot be judged only against the purchase price. Shareholders must consider the opportunity cost of the capital, the liability that remains outstanding, the contingent dilution above the conversion price and the effect of the repurchase and hedging package. A zero coupon lowers current interest cost, but it does not make the capital free.

At 30 June, before the Rigaku closing, Onto reported $1.253 billion of cash and cash equivalents, $628.9 million of marketable securities and a $1.472 billion carrying value for the notes. Cash plus securities therefore totalled about $1.882 billion. The approximate $720 million purchase price was around 38.3% of that pre-closing gross liquidity. This is a scale comparison, not a reconstruction of post-closing cash. It ignores intervening cash flow, restricted uses, transaction costs and the precise funding path.

Market value can overwhelm operating evidence

Because Onto selected fair-value accounting, movements in Rigaku’s valuation can become highly visible before the alliance’s industrial contribution is measurable. A simple sensitivity illustrates the scale: every ¥100 change per Rigaku share across 61,123,436 shares changes the gross value of Onto’s holding by about ¥6.112 billion. That arithmetic is not a forecast. It precedes currency translation, tax, liquidity discounts, contractual restrictions and the accounting presentation.

The sensitivity creates a reporting problem. A favourable valuation movement could flatter earnings while product conversion remains slow. An unfavourable movement could obscure useful qualification progress. Analysts will need to separate operating indicators from financial marks rather than letting one substitute for the other.

The same discipline applies to foreign exchange. Onto paid a fixed yen price but reports in dollars. Currency can alter the dollar value of the investment without changing Rigaku’s factories, patents, customer tests or order book. A market narrative that attributes every remeasurement to execution would confuse translation with operations.

What the alliance must prove

The first proof point is governance in practice. One nominated director is access to information and deliberation, not command. Investors should watch whether the seat is filled, whether the alliance creates visible joint decision forums and whether capital allocation or product-road-map decisions become more coordinated without compromising Rigaku’s independence.

The second is product specificity. Announcements should begin to name platforms, measurement problems, process nodes and qualification stages. Hybrid metrology only becomes an investable proposition when customers use it to make production decisions and buy it repeatedly.

The third is economic attribution. Onto should eventually make it possible to distinguish value created in its own product revenue from value retained inside Rigaku or expressed through fair-value gains. Useful evidence would include attributable bookings, installed systems, software and service attach, gross-margin effects, dividends and cash conversion.

The fourth is capital discipline. A strategic stake can become a reason to commit more capital when early results are ambiguous. The restrictions on additional purchases create boundaries, but they do not eliminate future choices. Investors should ask what conditions would justify more investment, what would cause Onto to stop, and how management compares the alliance with internal research, ordinary partnerships or smaller acquisitions.

Onto has bought a meaningful position at a moment when advanced packaging and three-dimensional device structures are making process control more demanding. The technical need is real. So is the distance between need and monetisation. The transaction deserves neither the automatic conglomerate discount applied to an unrelated stake nor the automatic synergy premium attached to a full merger. It deserves two ledgers.